Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Manoussakis

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Scandinavian Journal of Rheumatology. Supplement|January 1, 1986
Serological profiles in subgroups of patients with Sjögren's syndromeM N Manoussakis, A G Tzioufas, P J Pange, et al.
Clinical Immunology and Immunopathology|March 1, 1989
Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseasesM N Manoussakis, G K Papadopoulos, A A Drosos, et al.
Rheumatology (Oxford, England)|August 19, 2003
Oestrogen receptors in cultured epithelial cells from salivary glands of Sjogren's syndrome patientsE Kassi, P Moutsatsou, C E Sekeris, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1986
Cryoglobulinemia in primary Sjögren's syndrome: a monoclonal processA G Tzioufas, R Costello, M N Manoussakis, et al.
British Journal of Rheumatology|May 5, 1998
Headache in systemic lupus erythematosus: a controlled studyP P Sfikakis, D D Mitsikostas, M N Manoussakis, et al.
European Journal of Clinical Investigation|March 16, 2002
Absence of p53 gene mutations in skin fibroblasts derived from patients with systemic sclerosisP P Sfikakis, V G Gorgoulis, E K Kapsogeorgou, et al.
European Journal of Clinical Investigation|April 1, 1993
Immunologic and viral markers in the circulation of anti-HIV negative heroin addictsG N Dalekos, M N Manoussakis, E Zervou, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 18, 2006
Infliximab Therapy for Patients With Active and Refractory Spondyloarthropathies at the Dose of 3 mg/kg: A 20-Month Open TreatmentE P Cherouvim, E Zintzaras, K A Boki, et al.
European Journal of Clinical Investigation|July 1, 1992
Patients with anticardiolipin antibodies with and without antiphospholipid syndrome: their clinical features and beta 2-glycoprotein-I plasma levelsP G Vlachoyiannopoulos, S A Krilis, J E Hunt, et al.
Clinical Immunology and Immunopathology|September 1, 1987
Anticardiolipin antibodies in unselected autoimmune rheumatic disease patientsM N Manoussakis, A E Gharavi, A A Drosos, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Scandinavian Journal of Rheumatology. Supplement|January 1, 1986
Serological profiles in subgroups of patients with Sjögren's syndromeM N Manoussakis, A G Tzioufas, P J Pange, et al.
Clinical Immunology and Immunopathology|March 1, 1989
Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseasesM N Manoussakis, G K Papadopoulos, A A Drosos, et al.
Rheumatology (Oxford, England)|August 19, 2003
Oestrogen receptors in cultured epithelial cells from salivary glands of Sjogren's syndrome patientsE Kassi, P Moutsatsou, C E Sekeris, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1986
Cryoglobulinemia in primary Sjögren's syndrome: a monoclonal processA G Tzioufas, R Costello, M N Manoussakis, et al.
British Journal of Rheumatology|May 5, 1998
Headache in systemic lupus erythematosus: a controlled studyP P Sfikakis, D D Mitsikostas, M N Manoussakis, et al.
European Journal of Clinical Investigation|March 16, 2002
Absence of p53 gene mutations in skin fibroblasts derived from patients with systemic sclerosisP P Sfikakis, V G Gorgoulis, E K Kapsogeorgou, et al.
European Journal of Clinical Investigation|April 1, 1993
Immunologic and viral markers in the circulation of anti-HIV negative heroin addictsG N Dalekos, M N Manoussakis, E Zervou, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 18, 2006
Infliximab Therapy for Patients With Active and Refractory Spondyloarthropathies at the Dose of 3 mg/kg: A 20-Month Open TreatmentE P Cherouvim, E Zintzaras, K A Boki, et al.
European Journal of Clinical Investigation|July 1, 1992
Patients with anticardiolipin antibodies with and without antiphospholipid syndrome: their clinical features and beta 2-glycoprotein-I plasma levelsP G Vlachoyiannopoulos, S A Krilis, J E Hunt, et al.
Clinical Immunology and Immunopathology|September 1, 1987
Anticardiolipin antibodies in unselected autoimmune rheumatic disease patientsM N Manoussakis, A E Gharavi, A A Drosos, et al.
Pageof 5